Ref.No.1905/026EN July 16, 2019 Subject Inform about The Connected Transaction (Amendment) Attention President of the Stock Exchange of Thailand According to the Board of Directors Meeting No.9/2019
financial statements for the three-month period ended September30, 2019. The Group's sales and net profit totaled Bt3,088.3 million and Bt255.1 million, respectively, compared to Bt3,690.4 million and
characteristics under the Notification of the Ministry of Finance shall be prohibited to be major shareholder within the following periods: The prohibited characteristics Level of seriousness of behavior Maximum
to the following reasons: Unit: Million Baht - The cash-base patients’ revenue for Q2/2018 were Baht 1,240 million which increased from the Q2/2017 by Baht 190.6 million or 18.2% as a result of the
13.6 MB by 71.60 percent when compared to Q3/2017 at 19.1 MB. Therefore, the Company would like to clarify the operating results as following essential information: • Revenue Q3/2018, the Company and its
million or 11.6% due to the following reasons: Unit: Million Baht - The cash-base patients’ revenue for Q3/2018 were Baht 1,518.9 million which increased from Q3/2017 by Baht 245.3 million or 19.3% as a
request and application fee ( Approval request fee of 50,000 baht due to the following cases: ( (1) First time request for approval (the applicant has never requested an approval before); ( (2) Request for
request and application fee Approval request fee of 50,000 baht due to the following cases: (1) First time request for approval (the applicant has never requested an approval before); (2) Request for